EXACT Therapeutics AS - Notice of Annual General Meeting 2025

OSLO, May 28 2025: The Annual General Meeting of EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), will be held as a virtual meeting at 10:30 CEST on June 13, 2025.

The formal notice of the Annual General Meeting is attached and provides further information on the proceedings.
The documents are also available at www.exact-tx.com.



For more information, please contact:

Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com

John M. Edminson, CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com

About EXACT Therapeutics

EXACT Therapeutics is a clinical-stage precision medicine company utilizing the power of ultrasound and microbubbles to enable targeted drug delivery in oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be applied to a wide range of therapeutic agents within oncology and across a multitude of other indications, including brain diseases. EXACT Therapeutics’ shares are traded on Euronext Growth Oslo (EXTX). Further information may be found here:
www.exact-tx.com